BCR and prostate carcinoma: In contrast, a T2D polygenic risk score constructed from 113 SNPs showed no significant association with BCR (HR = 0.94, 95% CI = 0.68–1.29, p = 0.681), suggesting that the aggregate genetic risk for T2D does not broadly influence prostate cancer recurrence.